Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074881 | SCV001240485 | likely pathogenic | Retinal dystrophy | 2019-08-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001308869 | SCV001498344 | uncertain significance | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2022-09-26 | criteria provided, single submitter | clinical testing | This variant, c.2365_2367del, results in the deletion of 1 amino acid(s) of the CRB1 protein (p.Asn789del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with retinal dystrophy (PMID: 22065545). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 866672). This variant disrupts the p.Asn789 amino acid residue in CRB1. Other variant(s) that disrupt this residue have been observed in individuals with CRB1-related conditions (PMID: 24265693), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001553389 | SCV001774249 | pathogenic | not provided | 2019-12-19 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acid in a non-repeat region; Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 22065545) |
Baylor Genetics | RCV003473706 | SCV004211192 | likely pathogenic | Leber congenital amaurosis 8 | 2024-02-21 | criteria provided, single submitter | clinical testing |